E-mail us Sitemap ruslv

Partners

Merck Serono

Merck Serono is the division for innovative prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, manufactures and markets innovative small molecules and biopharmaceuticals to help patients with unmet medical needs. Its North American business operates in the United States and Canada as EMD Serono.
Merck Serono has leading brands serving patients with cancer (Erbitux®, cetuximab), multiple sclerosis (Rebif®, interferon beta-1a), infertility (Gonal-f®, follitropin alfa), endocrine and cardiometabolic disorders (Glucophage®, metformin); (Concor®, bisoprolol); (Euthyrox®, levothyroxine); (Saizen® and Serostim®, somatropin).
With an annual R&D expenditure of around EUR 1bn, Merck Serono is committed to growing its business in specialist-focused therapeutic areas including neurodegenerative diseases, oncology, fertility and endocrinology, as well as new areas potentially arising out of research and development in autoimmune and inflammatory diseases.
 
 
Cook
 
Since 1963, Cook has been a leader in developing health care devices that have improved lives around the world. With sales and marketing offices worldwide, we are at the forefront of medical research and product development for aortic intervention, critical care, diagnostics, endoscopy, gastroenterology, peripheral intervention, surgery, transplantology, urology, and women's health.
 

Erik Wennergaard
Vice-President CGE
 
Mr. Erik Wennergaard: AlenMed is a professional company with excellent knowledge about the local market. AlenMed's employees are highly-skilled experts with extensive and profound experience in their respective areas.
 
 
Axellus
 
Axellus Group, previously known as MöllerCollett, is a manufacturer of vitamins and healthy lifestyle products marketed under widely renowned brands.
Axellus Group includes large companies in Sweden, Norway, Finland, Denmark, Poland, and other countries. Axellus is a division of Orkla ASA.

Johannes Arbo Hoeg

Johannes Arbo Hoeg
Director Intermational Sales
 
Cathy Jolibois
Export Manager
 
Ms. Cathy Jolibois: AlenMed has a very professional team, showing commitment and creativity to our brands, and making you feel that your products are in good hands! Not to forget: their great hospitality!!
 
 
Certmedica

Certmedica has core competences in developing and marketing high quality standard medical devices throughout Europe and the world. It is a medium-sized company which develops and markets high-quality pharmaceutical products. As manufacturer of medical devices with a wide expertise, we are strongly set up on three locations close to Frankfurt/Main, Germany and count with a distribution network in more than 30 countries.

Ulrich Girke

Ulrich Girke
Director International Sales and Procurement
 
Mr. Ulrich Girke: Already during my first contact with the AlenMed team in Minsk I was not only impressed by their warm welcome, but also more importantly by their professional approach which was later confirmed in the efficient manner they handled the registration process for our product “formoline L112” I am sure that if AlenMed continues with the same dedication with the marketing and sales issues, that “Formoline L112” has found an excellent distributor in Belarus. Good luck to the whole team! 
 
  
Access Healthcare
 
Access Health Care AG was created in April 2006 to provide innovative, research based pharmaceutical companies access to, what will be for them, new geographical markets for their products.
Company’s main focus is the distribution, selling and marketing of products into key geographical markets. Access Health Care specializes in the key market segments of dermatology, gynaecology, oncology and urology.

Bruno Rosset
President & CEO
 

Hospira

Hospira is a global specialty pharmaceutical and medication delivery company driven by its vision of Advancing Wellness™. Bringing proven leadership and experience, Hospira provides solutions to help improve the productivity, safety and effectiveness of patient care. In early 2007, Hospira acquired Mayne Pharma to become the world leader in specialty generic injectable pharmaceuticals.

Michael Kotsanis

Phill Semmens

Michael Kotsanis
President Europe, Middle East & Africa
 
Phill Semmens
Commercial manager Europe, Middle East & Africa
 

Scott Voller

 

Scott Voller
Regional Consultant
 

 

 
 
Other partners
 

Igor Smirnov

Rauno Raukko

Igor Smirnov
Deputy Director, Internal Affairs
 
Rauno Raukko
CEO
 
 

Dr David J. Smith

 

David Smith
General Manager